CCI
31
3
CINF
53
2
DOW
44
10
VMC
57
4
AA
48
-12
UA
50
-9
BF.B
33
2
PRGO
39
3
TSCO
49
5
HP
48
3
ZION
65
2
BWA
48
2
LNC
39
3
KMI
67
-2
CRM
67
2
JPM
69
2
F
58
11
LH
43
-2
VFC
53
5
WM
79
3
CCI
31
3
CINF
53
2
DOW
44
10
VMC
57
4
AA
48
-12
UA
50
-9
BF.B
33
2
PRGO
39
3
TSCO
49
5
HP
48
3
ZION
65
2
BWA
48
2
LNC
39
3
KMI
67
-2
CRM
67
2
JPM
69
2
F
58
11
LH
43
-2
VFC
53
5
WM
79
3
Financhill
Back

SpringWorks Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55

SWTX
SpringWorks Therapeutics

Last Price:
39.03
Seasonality Move:
51.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

SpringWorks Therapeutics Price Quote

$39.03
+0.01 (+7.52%)
(Updated: November 23, 2024 at 5:56 AM ET)

SpringWorks Therapeutics Key Stats

Buy
55
SpringWorks Therapeutics (SWTX) is a Buy
Day range:
$36.24 - $39.61
52-week range:
$20.19 - $53.92
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
20.70
P/B ratio:
5.45%
Volume:
1.4M
Avg. volume:
1.2M
1-year change:
88.41%
Market cap:
$2.9B
Revenue:
$5.4M
EPS:
$-3.89

How Much Does SpringWorks Therapeutics Make?

Is SpringWorks Therapeutics Growing As A Company?

Data Unavailable

SpringWorks Therapeutics Stock Price Performance

What Is SpringWorks Therapeutics 52-Week High & Low?

SpringWorks Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy SpringWorks Therapeutics?

Is SpringWorks Therapeutics Cash Flow Positive?

  • What Is SWTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$208.8M
  • What Is SpringWorks Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $303.2M
  • What Is SpringWorks Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$108.8M

SpringWorks Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    SWTX return on invested capital is -51.38%
  • What Is SpringWorks Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -44.72%
  • What Is SWTX Return On Equity?
    ROE is a measure of profitability and is -51.38%

SpringWorks Therapeutics Earnings Date & Stock Price

SpringWorks Therapeutics Competitors

SpringWorks Therapeutics Dividend Yield

SpringWorks Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 5.26%
Revenue: 0% -10.59%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 67.33
Upside from Last Price: 72.56%

Major Shareholders

  • How many SWTX shares are owned by institutional investors?
    135M SWTX shares are owned by institutional investors
  • How many SWTX shares are owned by insiders?
    2.9M SWTX shares are owned by insiders